317 related articles for article (PubMed ID: 37316886)
1. The Prognostic and therapeutic value and clinical implications of fibroblast activation protein-α as a novel biomarker in colorectal cancer.
Kalaei Z; Manafi-Farid R; Rashidi B; Kiani FK; Zarei A; Fathi M; Jadidi-Niaragh F
Cell Commun Signal; 2023 Jun; 21(1):139. PubMed ID: 37316886
[TBL] [Abstract][Full Text] [Related]
2. Fibroblast activation protein-α expression in fibroblasts is common in the tumor microenvironment of colorectal cancer and may serve as a therapeutic target.
Greimelmaier K; Klopp N; Mairinger E; Wessolly M; Borchert S; Steinborn J; Schmid KW; Wohlschlaeger J; Mairinger FD
Pathol Oncol Res; 2023; 29():1611163. PubMed ID: 37614665
[No Abstract] [Full Text] [Related]
3. Increased expression of cancer-associated fibroblast markers at the invasive front and its association with tumor-stroma ratio in colorectal cancer.
Sandberg TP; Stuart MPME; Oosting J; Tollenaar RAEM; Sier CFM; Mesker WE
BMC Cancer; 2019 Mar; 19(1):284. PubMed ID: 30922247
[TBL] [Abstract][Full Text] [Related]
4. Altered expression of fibroblast activation protein-α (FAP) in colorectal adenoma-carcinoma sequence and in lymph node and liver metastases.
Solano-Iturri JD; Beitia M; Errarte P; Calvete-Candenas J; Etxezarraga MC; Loizate A; Echevarria E; Badiola I; Larrinaga G
Aging (Albany NY); 2020 May; 12(11):10337-10358. PubMed ID: 32428869
[TBL] [Abstract][Full Text] [Related]
5. Biomarkers in Tumor Microenvironment? Upregulation of Fibroblast Activation Protein-α Correlates with Gastric Cancer Progression and Poor Prognosis.
Hu M; Qian C; Hu Z; Fei B; Zhou H
OMICS; 2017 Jan; 21(1):38-44. PubMed ID: 28206814
[TBL] [Abstract][Full Text] [Related]
6. Predictive values of FAP and HGF for tumor angiogenesis and metastasis in colorectal cancer.
Ma TH; Gao CC; Xie R; Yang XZ; Dai WJ; Zhang JL; Yan W; Wu SN
Neoplasma; 2017; 64(6):880-886. PubMed ID: 28895412
[TBL] [Abstract][Full Text] [Related]
7. Fibroblast activation protein-α in tumor cells promotes colorectal cancer angiogenesis via the Akt and ERK signaling pathways.
Cao F; Wang S; Wang H; Tang W
Mol Med Rep; 2018 Feb; 17(2):2593-2599. PubMed ID: 29207091
[TBL] [Abstract][Full Text] [Related]
8. Colorectal cancer cell intrinsic fibroblast activation protein alpha binds to Enolase1 and activates NF-κB pathway to promote metastasis.
Yuan Z; Hu H; Zhu Y; Zhang W; Fang Q; Qiao T; Ma T; Wang M; Huang R; Tang Q; Gao F; Zou C; Gao X; Wang G; Wang X
Cell Death Dis; 2021 May; 12(6):543. PubMed ID: 34035230
[TBL] [Abstract][Full Text] [Related]
9. FAP positive fibroblasts induce immune checkpoint blockade resistance in colorectal cancer via promoting immunosuppression.
Chen L; Qiu X; Wang X; He J
Biochem Biophys Res Commun; 2017 May; 487(1):8-14. PubMed ID: 28302482
[TBL] [Abstract][Full Text] [Related]
10. Tumor necrosis factor receptor 2/AKT and ERK signaling pathways contribute to the switch from fibroblasts to CAFs by progranulin in microenvironment of colorectal cancer.
Wang L; Yang D; Tian J; Gao A; Shen Y; Ren X; Li X; Jiang G; Dong T
Oncotarget; 2017 Apr; 8(16):26323-26333. PubMed ID: 28412748
[TBL] [Abstract][Full Text] [Related]
11. Microenvironmental markers are correlated with lymph node metastasis in invasive submucosal colorectal cancer.
Sugai T; Yamada N; Osakabe M; Hashimoto M; Uesugi N; Eizuka M; Tanaka Y; Sugimoto R; Yanagawa N; Matsumoto T
Histopathology; 2021 Oct; 79(4):584-598. PubMed ID: 33884652
[TBL] [Abstract][Full Text] [Related]
12. Fibroblast activation protein overexpression and clinical implications in solid tumors: a meta-analysis.
Liu F; Qi L; Liu B; Liu J; Zhang H; Che D; Cao J; Shen J; Geng J; Bi Y; Ye L; Pan B; Yu Y
PLoS One; 2015; 10(3):e0116683. PubMed ID: 25775399
[TBL] [Abstract][Full Text] [Related]
13. High intratumoral expression of fibroblast activation protein (FAP) in colon cancer is associated with poorer patient prognosis.
Wikberg ML; Edin S; Lundberg IV; Van Guelpen B; Dahlin AM; Rutegård J; Stenling R; Oberg A; Palmqvist R
Tumour Biol; 2013 Apr; 34(2):1013-20. PubMed ID: 23328994
[TBL] [Abstract][Full Text] [Related]
14. Specific inhibition of fibroblast activation protein (FAP)-alpha prevents tumor progression in vitro.
Teichgräber V; Monasterio C; Chaitanya K; Boger R; Gordon K; Dieterle T; Jäger D; Bauer S
Adv Med Sci; 2015 Sep; 60(2):264-72. PubMed ID: 26057860
[TBL] [Abstract][Full Text] [Related]
15. Fibroblast Activation Protein and Tertiary Lymphoid Structure in Colorectal Cancer Recurrence.
Hayase S; Miyoshi N; Fujino S; Yasui M; Ohue M; Minami S; Kato S; Nagae A; Sekido Y; Hata T; Hamabe A; Ogino T; Takahashi H; Uemura M; Yamamoto H; Doki Y; Eguchi H
Anticancer Res; 2022 Dec; 42(12):5897-5907. PubMed ID: 36456145
[TBL] [Abstract][Full Text] [Related]
16. Oncogenesis, Microenvironment Modulation and Clinical Potentiality of FAP in Glioblastoma: Lessons Learned from Other Solid Tumors.
Shi Y; Kong Z; Liu P; Hou G; Wu J; Ma W; Cheng X; Wang Y
Cells; 2021 May; 10(5):. PubMed ID: 34068501
[TBL] [Abstract][Full Text] [Related]
17. [Expression and clinical significance of fibroblast activation protein in colorectal carcinoma tissue].
Cui B; Wang QW; Fang R; Du J; Zhang JM
Zhonghua Wei Chang Wai Ke Za Zhi; 2012 Apr; 15(4):392-5. PubMed ID: 22539390
[TBL] [Abstract][Full Text] [Related]
18. Fibroblast activation protein-positive fibroblasts promote tumor progression through secretion of CCL2 and interleukin-6 in esophageal squamous cell carcinoma.
Higashino N; Koma YI; Hosono M; Takase N; Okamoto M; Kodaira H; Nishio M; Shigeoka M; Kakeji Y; Yokozaki H
Lab Invest; 2019 Jun; 99(6):777-792. PubMed ID: 30683902
[TBL] [Abstract][Full Text] [Related]
19. Tumor bud-derived CCL5 recruits fibroblasts and promotes colorectal cancer progression via CCR5-SLC25A24 signaling.
Gao LF; Zhong Y; Long T; Wang X; Zhu JX; Wang XY; Hu ZY; Li ZG
J Exp Clin Cancer Res; 2022 Mar; 41(1):81. PubMed ID: 35241150
[TBL] [Abstract][Full Text] [Related]
20. [FIBROBLAST ACTIVATION PROTEIN (FAP) AS A POSSIBLE TARGET OF THE ANTITUMOR STRATEGY.].
Pleshkan VV; Alekseenko IV; Tyulkina DV; Kyzmich AI; Zinovyeva MV; Sverdlov ED
Mol Gen Mikrobiol Virusol; 2016; 34(3):90-97. PubMed ID: 30383930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]